Sanofi (NASDAQ:SNY) Shares Bought by Altrius Capital Management Inc

Altrius Capital Management Inc grew its position in Sanofi (NASDAQ:SNY - Free Report) by 5.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 161,940 shares of the company's stock after purchasing an additional 7,865 shares during the period. Sanofi comprises approximately 2.1% of Altrius Capital Management Inc's holdings, making the stock its 5th biggest holding. Altrius Capital Management Inc's holdings in Sanofi were worth $7,810,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Synergy Asset Management LLC acquired a new stake in Sanofi during the 4th quarter valued at $25,000. McClarren Financial Advisors Inc. grew its holdings in shares of Sanofi by 952.6% during the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company's stock worth $28,000 after purchasing an additional 543 shares during the last quarter. Sunbelt Securities Inc. increased its stake in shares of Sanofi by 72.1% in the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company's stock valued at $43,000 after buying an additional 313 shares in the last quarter. Sierra Ocean LLC bought a new position in shares of Sanofi in the fourth quarter valued at about $44,000. Finally, Versant Capital Management Inc bought a new stake in Sanofi during the 4th quarter worth about $54,000. Institutional investors own 14.04% of the company's stock.

Sanofi Trading Up 3.6 %

NASDAQ:SNY traded up $1.95 on Monday, hitting $56.42. 2,143,644 shares of the stock were exchanged, compared to its average volume of 2,360,149. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46. Sanofi has a 52 week low of $45.22 and a 52 week high of $58.97. The stock has a market capitalization of $143.17 billion, a price-to-earnings ratio of 22.64, a P/E/G ratio of 1.01 and a beta of 0.57. The company's 50-day moving average price is $51.65 and its 200 day moving average price is $52.59.

Sanofi (NASDAQ:SNY - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, hitting analysts' consensus estimates of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. On average, equities research analysts forecast that Sanofi will post 4.36 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on SNY shares. Sanford C. Bernstein raised shares of Sanofi to a "strong-buy" rating in a research note on Thursday, January 30th. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a "sell" rating to a "hold" rating in a report on Thursday, January 30th. Finally, StockNews.com cut shares of Sanofi from a "buy" rating to a "hold" rating in a research report on Thursday, December 12th. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $60.00.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.